Irinotecan hydrochloride trihydrate 20 mg/mL - Keputusan Carian

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

irinotecan act irinotecan hydrochloride trihydrate 500mg/25ml concentrated injection vial

medis pharma pty ltd - irinotecan hydrochloride trihydrate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

irinotecan act irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

medis pharma pty ltd - irinotecan hydrochloride trihydrate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

irinotecan act irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

medis pharma pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: (s)-lactic acid; water for injections; sodium hydroxide; sorbitol - for use as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum and in patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

omegapharm irinotecan irinotecan hydrochloride trihydrate 100 mg / 5 ml injection vial

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: water for injections; sodium hydroxide; sorbitol; lactic acid - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

omegapharm irinotecan irinotecan hydrochloride trihydrate 40 mg / 2 ml injection vial

cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: water for injections; sorbitol; lactic acid; sodium hydroxide - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

hospira irinotecan hydrochloride trihydrate iv infusion 100 mg

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: lactic acid; sorbitol; water for injections - small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non hodgkin's disease).

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

hospira irinotecan hydrochloride trihydrate iv infusion 40 mg

Kanada - Inggeris - Health Canada

irinotecan hydrochloride trihydrate for injection solution

fresenius kabi canada ltd - irinotecan hydrochloride (irinotecan hydrochloride trihydrate) - solution - 20mg - irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20mg - antineoplastic agents

Malta - Inggeris - Medicines Authority

irinotecan mylan generics 20mg/ml concentrate for solution for infusion

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Malta - Inggeris - Medicines Authority

irinotecan hydrochloride 20mg/ml concentrate for solution for infusion (100mg/5ml)

hospira uk limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg - antineoplastic agents